Cetera Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Cetera Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-120,677	Closed	-$909K	–	1782
2023 Q2	$909K	Sell	120,677 -44,810	-27%	-$337K	0.01%	751
2023 Q1	$1.46M	Buy	165,487 +145,112	+712%	+$1.28M	0.02%	555
2022 Q4	$186K	Sell	20,375 -193,620	-90%	-$1.77M	﹤0.01%	1461
2022 Q3	$1.73M	Buy	213,995 +19,706	+10%	+$159K	0.05%	397
2022 Q2	$1.46M	Buy	194,289 +90,952	+88%	+$684K	0.03%	465
2022 Q1	$970K	Sell	103,337 -91,157	-47%	-$856K	0.02%	625
2021 Q4	$1.56M	Buy	194,494 +157,087	+420%	+$1.26M	0.03%	463
2021 Q3	$364K	Sell	37,407 -13,139	-26%	-$128K	0.01%	1007
2021 Q2	$500K	Sell	50,546 -5,925	-10%	-$58.6K	0.01%	820
2021 Q1	$652K	Buy	56,471 +19,406	+52%	+$224K	0.02%	632
2020 Q4	$358K	Sell	37,065 -14,543	-28%	-$140K	0.01%	765
2020 Q3	$465K	Sell	51,608 -73,082	-59%	-$658K	0.02%	589
2020 Q2	$1.54M	Sell	124,690 -14,257	-10%	-$176K	0.07%	271
2020 Q1	$1.25M	Buy	138,947 +13,657	+11%	+$123K	0.07%	285
2019 Q4	$1.24M	Buy	125,290 +46,307	+59%	+$457K	0.05%	325
2019 Q3	$540K	Buy	78,983 +33,414	+73%	+$228K	0.02%	519
2019 Q2	$420K	Buy	45,569 +24,194	+113%	+$223K	0.02%	609
2019 Q1	$338K	Sell	21,375 -796	-4%	-$12.6K	0.02%	608
2018 Q4	$341K	Sell	22,171 -3,349	-13%	-$51.5K	0.02%	595
2018 Q3	$548K	Buy	+25,520	New	+$548K	0.03%	528
2016 Q4	–	Sell	-9,634	Closed	-$444K	–	801
2016 Q3	$444K	Sell	9,634 -12,410	-56%	-$572K	0.03%	446
2016 Q2	$1.11M	Sell	22,044 -1,842	-8%	-$92.7K	0.09%	242
2016 Q1	$1.28M	Sell	23,886 -2,176	-8%	-$116K	0.11%	199
2015 Q4	$1.71M	Buy	26,062 +1,190	+5%	+$78.2K	0.14%	169
2015 Q3	$1.41M	Sell	24,872 -104	-0.4%	-$5.88K	0.13%	173
2015 Q2	$1.48M	Buy	24,976 +1,807	+8%	+$107K	0.13%	181
2015 Q1	$1.44M	Sell	23,169 -2,296	-9%	-$142K	0.13%	186
2014 Q4	$1.48M	Buy	25,465 +1,242	+5%	+$71.9K	0.14%	174
2014 Q3	$1.31M	Buy	24,223 +933	+4%	+$50.4K	0.1%	173
2014 Q2	$1.22M	Buy	+23,290	New	+$1.22M	0.14%	185